Challenge
A leading pharma company was experiencing patient attrition and care friction for a rare disease asset, threatening outcomes and uptake for the product. The client needed to prioritized implementable digital / tech interventions for both near- and long-term solutions.
Approach
Scimitar hypothesized key patient journey outflows and benchmarked relevant technological solutions to address the issue. Hypotheses were tested through physician interviews and patient focus groups.
Impact
Produced comprehensive mapping and clustering of patient journey outflows, as well as acceptability and impact matrixes for each solution. Outputs supported prioritization of near-term pilot solutions and long-term technological platform investments.
